Foxo4-dri Synthetic Peptide Powder
NDC Package 87327-200-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Foxo4-dri Synthetic Peptide powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Sobei Genomics, Inc, this product is identified by NDC 87327-200.

Identification & Billing

NDC Package Code
87327-200-10
Package Description
25 g in 1 PACKAGE
Product Code
87327-200
11-Digit Billing Format
87327020010

Clinical Specifications

Proprietary Name
Foxo4-dri Synthetic Peptide
Non-Proprietary Name
Foxo4-dri Synthetic Peptide
Substance Name
Cat Fel D 1 Synthetic Peptide (cpavkrdvdlflt)
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
CAT FEL D 1 SYNTHETIC PEPTIDE (CPAVKRDVDLFLT) 1 g/g

Regulatory & Marketing

Labeler Name
Sobei Genomics, Inc
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
09-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87327-200-10 identifies a specific commercial package of 25 g in 1 package of Foxo4-dri Synthetic Peptide (UNFINISHED drug), a bulk ingredient labeled by Sobei Genomics, Inc. This powder is formulated for use and contains cat fel d 1 synthetic peptide (cpavkrdvdlflt) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sobei Genomics, Inc on September 01, 2025. The current certification is valid through December 31, 2027.

How is this Sobei Genomics, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87327020010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87327-200-10
11-Digit CMS (5-4-2)
87327-0200-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.